Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to ...

More than one million Americans are living with Parkinson’s disease, and another 90,000 people are expected to be diagnosed ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 ...

Parkinson's disease is the second most common neurodegenerative disease, affecting over 10 million people worldwide. Some forms of Parkinson's disease are characterized by an inability of cells to ...

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...

A new stem cell treatment could offer hope for people living with Parkinson’s - More than 1 million Americans live with the ...

A new initiative is set to explore the potential of repurposing existing medications to combat the symptoms of both Alzheimer’s and Parkinson’s diseases, aiming to accelerate the discovery of novel ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement pill called levodopa. It transformed the lives of millions of people.

Parkinson's disease does more than cause tremor and trouble walking. It can also affect sleep, smell, digestion and even ...

Scientists have found a key brain network that’s disrupted by Parkinson’s disease, according to a study published today in ...

The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say. The oral drug, dimethylfumarate, or DMF, ...

A new study suggests that a brain network linked to the execution of actions plays an important role in the neurodegenerative ...